SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-20-132132
Filing Date
2020-12-04
Accepted
2020-12-03 21:03:07
Documents
14
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2037548d1_10qa.htm   iXBRL 10-Q/A 32393
2 EXHIBIT 31.1 tm2037548d1_ex31-1.htm EX-31.1 10046
3 EXHIBIT 31.2 tm2037548d1_ex31-2.htm EX-31.2 10995
  Complete submission text file 0001104659-20-132132.txt   250524

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ruby-20200331.xsd EX-101.SCH 3186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ruby-20200331_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ruby-20200331_pre.xml EX-101.PRE 22710
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2037548d1_10qa_htm.xml XML 4793
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38586 | Film No.: 201368418
SIC: 2836 Biological Products, (No Diagnostic Substances)